Akebia Therapeutics, Inc. (AKBA)
1.66
+0.03
(+1.84%)
USD |
NASDAQ |
Dec 11, 16:00
1.665
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Cash from Operations (TTM): 32.40M for Sept. 30, 2025
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Pfizer Inc. | 13.08B |
| Plus Therapeutics, Inc. | -15.73M |
| Ironwood Pharmaceuticals, Inc. | 67.68M |
| Pyxis Oncology, Inc. | -72.44M |
| Karyopharm Therapeutics, Inc. | -89.35M |